HIT Consultant March 10, 2022
What You Should Know:
– Prenosis, Inc., a precision medicine company, announced a venture investment from PACE Healthcare Capital, an early-stage investment firm committed to improving health outcomes. This investment brings total funding in the company to over $20 million, including partnerships with Foxconn, Roche Diagnostics, the Defense Threat Reduction Agency, and others.
– Precision medicine company will use the funding to grow its industry-leading biological datasets, to advance its AI/ML capabilities to transform data into actionable insights for healthcare providers, drug developers and researchers, and to initiate the commercialization of its diagnostic and clinical decision support tools
Prioritize patients. Deliver the Right Therapy, Faster
Sepsis is currently one of the leading causes of mortality in U.S. hospitals, and...
Today's Sponsors
Today's Sponsor